Yohimbine impairs extinction of cocaine-conditioned place preference in an α2-adrenergic receptor independent process

  1. Adeola R. Davis1,
  2. Angela D. Shields2,
  3. Jonathan L. Brigman3,
  4. Maxine Norcross3,
  5. Zoe A. McElligott1,
  6. Andrew Holmes3, and
  7. Danny G. Winder1,2,4,5
  1. 1 Vanderbilt Brain Institute, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0615, USA;
  2. 2 Department of Molecular Physiology and Biophysics, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0615, USA;
  3. 3 Section on Behavioral Science and Genetics, Laboratory for Integrative Neuroscience, National Institute on Alcoholism and Alcohol Abuse, National Institutes of Health, Rockville, Maryland 20852-9411, USA;
  4. 4 Kennedy Center For Human Development, Vanderbilt University Medical Center, Nashville, Tennessee 37232-0615, USA

Abstract

Extinction, a form of learning that has the ability to reshape learned behavior based on new experiences, has been heavily studied utilizing fear learning paradigms. Mechanisms underlying extinction of positive-valence associations, such as drug self-administration and place preference, are poorly understood yet may have important relevance to addiction treatment. Data suggest a major role for the noradrenergic system in extinction of fear-based learning. Employing both pharmacological and genetic approaches, we investigated the role of the α2-adrenergic receptor (α2-AR) in extinction of cocaine-conditioned place preference (CPP) and glutamatergic transmission in the bed nucleus of the stria terminalis (BNST). We found that pre-extinction systemic treatment with the α2-AR antagonist yohimbine impaired cocaine CPP extinction in C57BL/6J mice, an effect that was not mimicked by the more selective α2-AR antagonist, atipamezole. Moreover, α2A-AR knockout mice exhibited similar cocaine CPP extinction and exacerbated extinction impairing effects of yohimbine. Using acute brain slices and electrophysiological approaches, we found that yohimbine produces a slowly evolving depression of glutamatergic transmission in the BNST that was not mimicked by atipamezole. Further, this action was extant in slices from α2A-AR knockout mice. Our data strongly suggest that extinction-modifying effects of yohimbine are unlikely to be due to actions at α2A-ARs.

Footnotes

| Table of Contents